YSC1
Yeast from Saccharomyces cerevisiae
Type I
Synonym(s):
(Bakers yeast)
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Recommended Products
biological source
Saccharomyces cerevisiae
type
Type I
form
powder or solid
application(s)
food and beverages
microbiology
storage temp.
2-8°C
General description
Yeast from Saccharomyces cerevisiae (Baker′s yeast) is the oldest microbial starter. It is a facultative anaerobe.
Application
Yeast from Saccharomyces cerevisiae has been used:
- as a biocatalyst for the anode of yeast microbial fuel cell
- for the production of ethanol for fuel use
- to prepare yeast extract
Biochem/physiol Actions
Yeast from Saccharomyces cerevisiae (Baker′s yeast) is used as a protein supplement, energy booster and immune enhancer. It serves as a dough leavening agent in bread production by converting the fermentable sugars to CO2 and ethanol. Baker′s yeast exhibits aroma, anti-molding and nutritive properties. It acts as a cell factory.
Caution
Autolyzes in aqueous buffer at 37 °C.
Preparation Note
Dried to avoid inactivation of enzymes.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Inventions on baker's yeast strains and specialty ingredients
Recent Patents on Food, Nutrition & Agriculture, 1(2), 104-132 (2009)
Engineering baker?s yeast: room for improvement
Trends in biotechnology, 17(6), 237-244 (1999)
Scientific reports, 8(1), 2348-2348 (2018-02-07)
Genetic variability affects the response to numerous xenobiotics but its role in the clinically-observed irregular responses to general anesthetics remains uncertain. To investigate the pharmacogenetics of volatile general anesthetics (VGAs), we developed a Serial Anesthesia Array apparatus to expose multiple
Miniature flowing atmospheric-pressure afterglow ion source for facile interfacing of CE with MS
Electrophoresis, 31(21), 3597-3605 (2010)
Electrostatically enhanced performance of a yeast-based microbial fuel cell
Royal Society of Chemistry Advances, 5(25), 19203-19205 (2015)
Protocols
This procedure may be used for the determination of Lyticase activity using Baker’s yeast as the substrate.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service